Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China flag China · Delayed Price · Currency is CNY
45.11
-1.00 (-2.17%)
May 19, 2026, 10:35 AM CST

SHE:300347 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
6,9516,7136,4747,2897,0025,187
Other Revenue
119.47119.47129.0494.9383.9326.17
7,0706,8336,6037,3847,0855,214
Revenue Growth (YoY)
8.65%3.48%-10.58%4.21%35.91%63.32%
Cost of Revenue
5,1874,9604,3594,5394,2772,943
Gross Profit
1,8831,8732,2442,8452,8082,271
Selling, General & Admin
961960.56944.45837.52780.02676.88
Research & Development
261.22257.64238.39261.56234.62211.83
Other Operating Expenses
44.2931.7122.219.157.1712.5
Operating Expenses
1,2731,2651,2351,1551,046926.93
Operating Income
610.62608.471,0091,6901,7631,344
Interest Expense
-80.97-90.56-141.24-119.9-83.18-24.91
Interest & Investment Income
460.29448.94256.86568.02330.09568.16
Currency Exchange Gain (Loss)
-16.95-16.9518.022.6120.13-11.83
Other Non Operating Income (Expenses)
-8.38-9.26-6.59-3.32-6.88-1.48
EBT Excluding Unusual Items
964.61940.641,1372,1382,0231,874
Impairment of Goodwill
-20.28-20.28-5-29.16--
Gain (Loss) on Sale of Investments
259.6842.26-501.69352.77535.861,815
Gain (Loss) on Sale of Assets
2.613.653.56-0.19-0.09-0.53
Asset Writedown
2.73-0.22---0.45-
Other Unusual Items
56.1837.1631.0527.2427.1-3.96
Pretax Income
1,2661,003664.462,4892,5853,685
Income Tax Expense
240.38198.16216.63338.61313.65292.86
Earnings From Continuing Operations
1,025805.06447.832,1502,2723,392
Minority Interest in Earnings
-253.6982.83-42.69-125.08-265.17-517.54
Net Income
771.46887.89405.142,0252,0072,874
Net Income to Common
771.46887.89405.142,0252,0072,874
Net Income Growth
129.92%119.15%-79.99%0.91%-30.19%64.26%
Shares Outstanding (Basic)
842856863865865868
Shares Outstanding (Diluted)
842856863865866871
Shares Change (YoY)
-2.39%-0.83%-0.22%-0.07%-0.62%9.01%
EPS (Basic)
0.921.040.472.342.323.31
EPS (Diluted)
0.921.040.472.342.323.30
EPS Growth
135.54%120.99%-79.94%0.86%-29.70%50.69%
Free Cash Flow
1,021903.72740.45836.68908.91,055
Free Cash Flow Per Share
1.211.060.860.971.051.21
Dividend Per Share
0.1260.1260.3000.5680.5500.500
Dividend Growth
-58.00%-58.00%-47.18%3.27%10.00%66.67%
Gross Margin
26.64%27.41%33.99%38.53%39.64%43.55%
Operating Margin
8.64%8.91%15.29%22.89%24.88%25.77%
Profit Margin
10.91%13.00%6.14%27.42%28.32%55.13%
Free Cash Flow Margin
14.44%13.23%11.21%11.33%12.83%20.24%
EBITDA
824.11820.31,2151,8761,9211,458
EBITDA Margin
11.66%12.01%18.40%25.40%27.12%27.97%
D&A For EBITDA
213.49211.84205.22185.06158.69114.71
EBIT
610.62608.471,0091,6901,7631,344
EBIT Margin
8.64%8.91%15.29%22.89%24.88%25.77%
Effective Tax Rate
18.99%19.75%32.60%13.61%12.13%7.95%
Revenue as Reported
7,0706,8336,6037,3847,0855,214
Advertising Expenses
-13.0514.119.9719.2414.45
Source: S&P Global Market Intelligence. Standard template. Financial Sources.